Nibe shares: The contract covers the production and supply of Universal Rocket Launchers with a range of up to 300 kilometres—an advanced system being manufactured in India for the first time for international use.

Indian stock markets surged on Monday, with Sensex and Nifty50 opening higher, fueled by gains in banking and auto sectors. This positive momentum followed U.S. President Trump s decision to extend trade talks with the European Union, alleviating immediate trade concerns. M&M, Power Grid, and ICICI Bank were among the top gainers on the Sensex.

Smallcap stocks have surged, adding Rs 7.3 lakh crore to investor wealth in just 10 sessions, fueled by stock-specific triggers and retail investor enthusiasm. While some experts see justified valuations due to growth, others caution against stretched valuations and potential herd behavior, highlighting the risks of chasing momentum after a prior correction. The rally s sustainability remains questionable.

JM Financial maintains a Buy call on Sun Pharmaceutical Industries, setting a revised target price of Rs 2025. Sun Pharma s Q4FY25 results showed an 8% YoY top-line growth, driven by India formulations and global specialty sales, despite a decline in US formulations. Future growth hinges on Ilumya s Phase 3 data, Leqselvi s launch, and the Checkpoint Therapeutics acquisition.

Global natural gas demand is surging, driven by industrial growth in developing nations. The International Energy Agency reports a 2.7% rise in 2024, exceeding pre-pandemic levels. Asia accounts for 40% of this increase. Industrial and power sectors are key drivers. Despite rising demand, gas prices remain subdued. China s consumption is set to increase by 6.5%.

ICICI Securities recommends buying Honasa Consumer shares, setting a target price of Rs 400. The firm anticipates revenue growth for Honasa. They project significant increases in EBITDA and PAT through FY27. While reducing FY26 EPS estimates, ICICI Securities maintains a positive outlook. Key risks include competition and execution challenges. The brokerage reaffirms its BUY rating, citing potential for margin recovery.

Jerome Powell spoke during the university’s baccalaureate service, addressing students and faculty at a time of continued scrutiny of the Federal Reserve.

Balkrishna Industries shares: Although the company s revenue grew by 5% year-on-year to Rs 2,838 crore and EBITDA edged up by 1% to Rs 703 crore, its EBITDA margin declined by 115 basis points year-on-year, settling at 24.78%.

The Indian Rupee saw a significant rise against the US dollar in early trading. This appreciation is supported by a weaker dollar index and positive movement in domestic stock markets. Foreign fund inflows and a large dividend announcement from the Reserve Bank of India also boosted the rupee. Market participants are awaiting key economic data releases this week.